ziftomenib
kura oncology
['ko-539', 'komet-001', 'leusm', 'manifest,(-manifest-2),(-manifest2),(-manifest 2),(-manifest-i),(-manifesti),(-manifest i)', 'ziftomenib', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'kura ']
congress | #ash22
harry erba presents data from the komet-001 phase i/ii trial showing the menin-kmt2a inhibitor ziftomenib (ko-539) has efficacy in r/r aml. #leusm #medicalcongress 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm